­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hoc/23996/17
    TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
    01-Jan-1970 Research 2017 : October - December
    Binsheng Fu, Wei Meng, Xiancheng Zeng, Hui Zhao, Wei Liu, Tong Zhang

    Thioredoxin reductase 1 (TXNRD1) which is a selenocysteine-containing protein is overexpressed in many malignancies. Its role\nin the hepatocellular carcinoma (HCC) prognosis has not been investigated. In this study, we investigated whether TXNRD1\nfunctions as an independent prognostic factor for HCC patients.We found TXNRD1 was overexpressed in HCC tissues and cells,\nimmunohistochemical analysis suggested TXNRD1 was elevated in 57 of 120 (47.5%) clinical samples, and its level was increased\nwith the increasing clinical stage. In addition, TXNRD1 expression was positively correlated with clinical stage (

    How to Cite this Article
    CC Compliant Citation: Binsheng Fu, Wei Meng, Xiancheng Zeng, Hui Zhao, Wei Liu, and Tong Zhang, â??TXNRD1 Is an Unfavorable\nPrognostic Factor for Patients with Hepatocellular Carcinoma,â? BioMed Research International, vol. 2017, Article ID 4698167, 8 pages,\n2017. doi:10.1155/2017/4698167, http://creativecommons.org/licenses/by/4.0/.
    Download Full Text